About INSILICA LLC
Insilica provides end-to-end automation for regulatory-grade risk assessments, OEL/HBEL reports, and REACH dossiers using AI and expert validation. The company is backed by NIH, NSF, and EU research grants and trusted by regulatory agencies, pharmaceutical companies, and research consortia.
End-to-end automation for regulatory-grade risk assessmentsCurated data infrastructure with 135+ FAIR-compliant datasetsIntelligent analysis using AI models for metabolism, QSAR, ADME, and moreExpert validation through human-in-the-loop toxicologistsGeneration of OEL/HBEL reports, REACH dossiers, and Data Evaluation Records
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| FDA CLINICAL TRIALS.GOV REPORTING &ASD RESEARCH PROGRAM - SBIR III | Department of Health and Human Services | $1.2M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INSILICA LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.